A Phase III Trial Examining the Safety and Efficacy of an Experimental 12-Month Contraceptive Vaginal Ring
Study Summary
The research study will examine the safety and efficacy of an experimental contraceptive vaginal ring designed to last for 12 months and contains lower dosage of hormones than the birth control pill. Women enrolled in the study will participate in seven study visits over the course of one year and up to three telephone follow-up contacts over a period of 6 months, if needed. As part of the study, women will receive physical and gynecological exams and complete daily diaries. All visits will take place at a private setting at the University of Chicago. Participants will receive $250 for participation in the seven study visits. The study may result in a new birth control alternative for women.
Participation Details
- Women between 18 and 39 years old
- Interested in trying a new contraceptive vaginal ring
To be eligible you must be:
- In good general health
- Currently sexually active
- Willing to discontinue your current contraceptive method
Study Director/Principal Investigator: Melissa Gilliam, MD
Department: Obstetrics and Gynecology, Section of Family Planning
For more information, contact:
Rachael Pius
5841 S. Maryland Avenue, MC 2050
Chicago, IL 60637
(773) 834-7727
rpius@babies.bsd.uchicago.edu
IRB: #14624A
